GENI — Genincode Income Statement
0.000.00%
Last trade - 00:00- £7.03m
- £4.34m
- £2.16m
Annual income statement for Genincode, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.961 | 1.15 | 1.43 | 2.16 |
| Cost of Revenue | ||||
| Gross Profit | 0.523 | 0.593 | 0.632 | 1.02 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 2.01 | 5.3 | 7.33 | 9.31 |
| Operating Profit | -1.05 | -4.15 | -5.9 | -7.15 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -1.05 | -4.14 | -5.75 | -7.02 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -1.17 | -4.14 | -5.56 | -7.02 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -1.17 | -4.14 | -5.56 | -7.02 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -1.17 | -4.14 | -5.56 | -7.02 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.012 | -0.039 | -0.058 | -0.073 |
| Dividends per Share |